|
Ramandeep Kaur Virk
Senior Regulatory Specialist
Health Sciences Authority Singapore
Singapore
Singapore
|
Dr. Virk is a Senior Regulatory Specialist (Clinical Reviewer) at the Advanced Therapy Products Branch (ATPB) within the Health Sciences Authority (HSA) in Singapore. Her expertise lies in the regulation and clinical evaluation of Cell, Tissue and Gene Therapy Products. She holds an MD in Microbiology from MDU, Rohtak, India, and subsequently pursued her PhD at the National University of Singapore (NUS) after relocating to Singapore. During her extensive 10-year research tenure, Dr. Virk's work primarily focused on understanding the molecular epidemiology and evolution of human influenza viruses. This background equips her with a deep understanding of infectious diseases and molecular biology, which undoubtedly enriches her contributions to the regulatory and clinical evaluation of advanced therapy products at HSA.